Skip to content

Comparison Between Type A Botulinum Toxin Injection and Corticosteroid Injection in the Treatment of Tennis Elbow

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00395616
Enrollment
40
Registered
2006-11-03
Start date
2006-11-30
Completion date
Unknown
Last updated
2006-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tennis Elbow, Type A Botulinum Toxin

Brief summary

Humeral lateral epicondylitis or tennis elbow is a common painful elbow disorder. The cause of tennis elbow is the chronic overload of bone-tendon junction. High prevalence of tennis elbow has a direct impact on the workplace productivity and quality of life. Steroid injection is the very few methods proved to have short-term efficacy in tennis elbow treatment, but it has potential adverse effects like tendon rupture. Temporary paralysis of muscle after botulinum toxin injection may reduce the physical demands and facilitate the normal repair mechanism during recovery. Preliminary studies suggested that botulinum toxin injection is effective in treating tennis elbow. The objective of this study is to compare the effects of botulinum toxin injection with corticosteroid injection in tennis elbow treatment.

Interventions

DRUGBotox (drug)

Sponsors

E-DA Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Pain at the lateral epicondyle of the elbow * Tenderness at the lateral epicondyle of the elbow * Pain on resisted extension of the wrist

Exclusion criteria

* Local injection of steroid within 3 months * Previous elbow trauma or operations * Pregnancy * Systemic neuromuscular disorders such as myasthenia gravis

Design outcomes

Primary

MeasureTime frame
WHOQOL-BREF
visual analogue scale for pain
grip strength

Countries

Taiwan

Contacts

Primary ContactYu-Ching Lin, MD
yuchinglin2003@yahoo.com.tw886-7-6150011

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026